Efficacy and Safety of Oral Nalbuphine Extended Release in Prurigo Nodularis: Results of a Phase 2, Randomized, Controlled Trial with an Open Open-Label Extension Phase. J of Skin [Internet]. 2021 Jan. 1 [cited 2025 Apr. 19];5(1):s29. Available from: https://skin.dermsquared.com/skin/article/view/1180